About Us

  • Dr. Fernando Muzzio // President, Integra CMS


    Dr. Fernando Muzzio is the president of Integra Continuous Manufacturing Systems, where he drives company strategy, applying extensive experience in pharmaceutical product and process design, with emphasis on continuous manufacturing. He is also the Director of the National Science Foundation (NSF) Engineering Research Center on Structured Organic Particulate Systems (C-SOPS) and a Distinguished Professor at Rutgers University in the department of Chemical and Biochemical Engineering, and a member of the graduate program in Pharmaceutics at the Rutgers School of Pharmacy.

    Dr. Muzzio is a consulting member of the FDA Committee on Pharmaceutical Sciences and clinical pharmacology and a member of the USP expert committee on Continuous Manufacturing. As a core advocate, researcher, and developer of continuous manufacturing for the industry, Dr. Muzzio has built an extensive network, and has made a profound impact on the industry. His work as the Rutgers Program Director of the Janssen/Rutgers partnership in advanced Pharmaceutical Manufacturing to redevelop the manufacturing process for Prezista resulted in implementation of the Inspire Continuous Manufacturing program at Rutgers and Janssen Pharmaceutica in Gurabo, Puerto Rico.

    Dr. Muzzio holds a PhD from the University of Massachusetts at Amherst and a BS degree from the University of Mar del Plata in Argentina, both in Chemical Engineering. He has authored more than 270 peer-reviewed scientific articles and numerous book chapters and patents. In 2016, the NJ Inventors Hall of Fame awarded Dr. Muzzio the Inventor of the Year Award for his contributions to continuous pharmaceutical manufacturing.

  • Daisy Rivera Muzzio // COO, Integra CMS


    Daisy Rivera Muzzio is the business owner and president of Acumen BioPharma, and serves as Chief Operating Officer (COO) at Integra CMS. In her Integra CMS role, she is responsible for all business operations and management of contractual alliances, drawing on her deep expertise in the evaluation and risk assessment of licensing generic formulations, and conducting cross-functional analyses for licensing and acquisition of several major platform technologies.

    Rivera-Muzzio holds a Master of Science in Industrial Pharmacy and Bachelor of Science in Pharmacy from the University of Puerto Rico. She earned her MBA from Massachusetts Institute of Technology (MIT) in Cambridge, MA. She has served as the VP of Programs for the MIT Alumni NNJ Chapter and as co-Chair of the NJ Chapter of Licensing Executive Society (LES), and volunteers to support STEM education for underprivileged children. She is also an active member of the MIT Educational Council of Princeton, NJ and of the Healthcare Businesswomen Association (HBA).

  • Dr. Douglas B. Hausner // Lead Consultant, Integra CMS


    Dr. Doug Hausner is Lead Consultant at Integra CMS, with more than a decade of experience working alongside Dr. Muzzio and his team. His major expertise is in understanding the combined technical and regulatory effect of continuous processes to help adopters develop effective strategies for process implementation, particularly regarding the application of PAT methods to continuous processes.

    Dr. Hausner received his doctorate in Physical and Analytical Chemistry from Temple University in 2009. He has extensive laboratory and teaching experience covering a range of analysis techniques, notably spectroscopy and microscopy. He is also Associate Director at the NSF Engineering C-SOPS Center, in addition to being a member of the USP expert committee on Continuous Manufacturing.

  • Dr. Alberto Cuitiño // Senior Consultant, Integra CMS


    Dr. Alberto Cuitiño is a Senior Consultant at Integra CMS, where he applies his extensive experience in continuous pharmaceutical processing to the analysis and design of pharmaceutical compaction processes. He is a recognized expert in powder characterization, compaction, tablet dissolution, non-destructive testing methods and process modeling. He is also Professor and Chair of Mechanical and Aerospace Engineering at Rutgers University.

    As a former Site Leader at Rutgers University of the NSF Engineering Research Center for Structured Organic Particulate Systems (ERC-SOPS), Dr. Cuitiño was the Leader of the Product Characterization team with responsibilities including leading and managing a major research thrust focused on the performance of pharmaceutical dosage from APIs to tablet dissolution. He also played a critical role in the partnership between Rutgers University, Johnson & Johnson and the NSF Partnerships for Innovation/Accelerating Innovation Research program.

    Dr. Cuitiño earned his PhD in Solid Mechanics and MS degree in Applied Mathematics from Brown University, as well as a Civil Engineering Diploma from the University of Buenos Aires, Argentina. He is also a graduate member of programs in Pharmaceutical Sciences at Rutgers Ernest Mario School of Pharmacy and Chemical and Biochemical Engineering at Rutgers Engineering. He is a current fellow of the American Society of Mechanical Engineers.

  • Dr. Marianthi G. Ierapetritou // Senior Consultant, Integra CMS


    Dr. Marianthi Ierapetritou is a Senior Consultant at Integra CMS with more than 15 years of experience in pharmaceutical manufacturing. She is also a Distinguished Professor and former Chair of the Department of Chemical & Biochemical Engineering at Rutgers University, and a Special Government Employee (SGE) Consultant to the FDA under the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (ACPS-CP).

    She led the team at Rutgers University that developed the flowsheet modeling framework that is quickly becoming the worldwide standard at companies, major universities, and regulatory agencies for analysis, design, and optimization of continuous manufacturing systems.

    Dr. Ierapetritou gained her PhD from the Chemical Engineering Department at Imperial College, London, UK with research interests in computer-aided process and product design; production planning, scheduling and supply chain management; modeling and optimization of pharmaceutical processes; and metabolic engineering and optimization. She has authored three books and more than 200 peer-reviewed scientific articles and book chapters.

  • Stephen V. Hammond // Senior Consultant, Integra CMS


    Steve Hammond is a Senior Consultant at Integra CMS with more than 39 years of analytical industry experience at Pfizer Pharmaceuticals. His expertise lies in the development and deployment of Process Analytical Sciences, including forensic analysis support to the plant network.

    As a core driver of the development and deployment of Process Analytical Technologies (PAT) during the development of Pfizer’s Continuous Manufacturing platform, he gained insight into the successful integration of real time measurement systems and associated control systems at critical points of the manufacturing process flow (to ensure process robustness and performance, leading to product quality and compliance).

    Hammond holds an MS in Analytical Chemistry from the University of Kent, UK. He is a Graduate of the Royal Institute of Chemistry, London, UK and obtained the status of Chartered Chemist in the UK by examination. He is also a member of the Royal Society of Chemistry.

  • San Kiang // Senior Consultant, Integra CMS


    San Kiang is a Senior Consultant in continuous processing for Active Pharmaceutical Ingredients (API) and Drug Product (DP) process development with focus on particle engineering, pharmaceutical composite materials (PCM), co-processing and pharmaceutical process scale-up. He is also a contributor to Rutgers University research to enable continuous manufacturing of API and Continuous Direct Compression of finished product with emphasis on process transfer to pilot and manufacturing scales.

    Kiang has developed PCM in which API and excipients are combined under controlled conditions to produce composite materials with unique properties that can be used to address some common issues in formulation development. He has also developed particle engineering technologies to enable the use of problematic API in direct compression DP platforms.

    He earned his ScD, MS and BS in Chemical Engineering from Columbia University, and has served as a Research Professor at Rutgers University, Department of Chemical and Biochemical Engineering, conducting research projects on continuous manufacturing in both API and DP and material science related to pharmaceuticals.